BVF Partners
- Company typePrivate
- Founded1993
- HeadquartersSan Francisco, United States
- Headcount—
- GTM typeB2B
- OfferingServices
BVF Partners firmographics
Firmographics- Name
- BVF Partners
- Legal name
- BVF Partners L.P.
- Website
- https://bvfpartners.com
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Ownership category
- akta.pro rank
BVF Partners industry classification
Industry- Product category
- Biotech Hedge Fund Management
- NAICS
- Portfolio Management and Investment Advice (52394)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where BVF Partners is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
BVF Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Others
BVF Partners product offering
Product offeringCore offering
BVF Partners is a San Francisco-based investment firm, operating as BVF Partners L.P., that manages hedge funds focused exclusively on biotechnology and life sciences companies. The firm deploys capital into clinical-stage biotech companies via private placements, post-IPO equity offerings, and Series B financings, both as lead investor and as a participating institutional investor.
Product overview
BVF Partners L.P. is a healthcare-focused investment firm specializing in biotech investments. The company does not offer technology products or services but rather provides investment capital to biotechnology companies through private placements, equity financings, and other investment mechanisms. As an investment fund, BVF Partners participates in funding rounds for companies including Absci Corporation, Entera Bio, Immunic, Ambrosia Biosciences, MoonLake Immunotherapeutics, and others developing pharmaceutical and biotechnology therapies.
Differentiator
Problem solved
Functional benefit
Products and services
- BVF Partners L.P. Biotech Hedge Fund
Companies that use BVF Partners
Customer profileIdeal customer profiles2 records
BVF Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BVF Partners partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights3 records
BVF Partners competitors and assessment
Company assessmentDirect peers
- Baker Bros. Advisors: Long-standing biotech-specialist investment advisor with a virtually identical mandate to BVF — public and private equity investments in clinical-stage life sciences companies.
- Perceptive Advisors: Biotech-specialist investment firm with comparable clinical-stage focus and active role in private placements and PIPEs across the same universe of issuers.
- EcoR1 Capital: Biotech-specialist hedge fund that co-invests with BVF in private placements and PIPE financings, sharing a comparable biotech-only mandate.
- Cormorant Asset Management: Healthcare-focused investment manager with a similar biotech equity mandate, frequently participating alongside BVF in mid-cap clinical-stage financings.
- RA Capital Management: Healthcare-focused crossover fund frequently co-investing alongside BVF in biotech PIPE and private placements; near-perfect mandate overlap on clinical-stage therapeutics.
- OrbiMed Advisors: Healthcare-dedicated investment firm across private equity, venture, and public equity — directly comparable to BVF's biotech focus and similar financing role in deals such as Immunic.
- Redmile Group: Healthcare-focused investment firm co-leading deals alongside BVF (e.g., Ambrosia Biosciences Series B) with overlapping biotech-only investment universe.
- Deerfield Management: Healthcare investment manager combining public equities and venture/private capital; co-investor with BVF in financings such as Foghorn Therapeutics.
- Avidity Partners: Biotech-focused fund co-investing with BVF in Immunic's placement; near-identical clinical-stage biotech mandate.
Broad incumbents
- Janus Henderson Investors: Large diversified asset manager participating in biotech financings (e.g., Diagonal Therapeutics) as one of many verticals; less specialized than BVF but a co-investor in the same deals.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
BVF Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
BVF Partners leadership team
Management profileNumber of profiles
BVF Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BVF Partners M&A and investment
M&A and investmentM&A
Investments3 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BVF Partners
What does BVF Partners do?
BVF Partners is a San Francisco-based investment firm, operating as BVF Partners L.P., that manages hedge funds focused exclusively on biotechnology and life sciences companies. The firm deploys capital into clinical-stage biotech companies via private placements, post-IPO equity offerings, and Series B financings, both as lead investor and as a participating institutional investor.
Is BVF Partners a public or private company?
BVF Partners is a private company. It is classified as unknown and is currently operating.
When was BVF Partners founded?
BVF Partners was founded in 1993.
Where is BVF Partners based?
BVF Partners is headquartered in San Francisco, United States, in the North America region.
Who are BVF Partners's main competitors?
Direct peers on record are Baker Bros. Advisors, Perceptive Advisors, EcoR1 Capital, Cormorant Asset Management, RA Capital Management, OrbiMed Advisors, Redmile Group, Deerfield Management and Avidity Partners. Janus Henderson Investors is listed as a broad incumbent.
Does BVF Partners have an API?
No public API is recorded for BVF Partners.
What industry is BVF Partners in?
BVF Partners's product category is Biotech Hedge Fund Management. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 52394 and its SIC code is 6282.